AU2002221897A1 - Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma - Google Patents

Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma

Info

Publication number
AU2002221897A1
AU2002221897A1 AU2002221897A AU2189702A AU2002221897A1 AU 2002221897 A1 AU2002221897 A1 AU 2002221897A1 AU 2002221897 A AU2002221897 A AU 2002221897A AU 2189702 A AU2189702 A AU 2189702A AU 2002221897 A1 AU2002221897 A1 AU 2002221897A1
Authority
AU
Australia
Prior art keywords
allergic
histaminase
vegetable origin
septic shock
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221897A
Inventor
Olivia Befani
Rodolfo Federico
Pier Francesco Mannaioni
Emanuela Masini
Mircea Alexandru Mateescu
Bruno Mondovi'
Alfredo Vannacci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite du Quebec a Montreal
Universita degli Studi di Roma Tre
Universita degli Studi di Roma La Sapienza
Original Assignee
Universite du Quebec a Montreal
Universita degli Studi di Roma Tre
Universita degli Studi di Roma La Sapienza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite du Quebec a Montreal, Universita degli Studi di Roma Tre, Universita degli Studi di Roma La Sapienza filed Critical Universite du Quebec a Montreal
Publication of AU2002221897A1 publication Critical patent/AU2002221897A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03022—Diamine oxidase (1.4.3.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present document describes a method of treating a histamine-mediated condition by administering an effective amount of a histaminase of vegetable origin to a subject in need. The histamine-mediated condition may be an allergic shock, septic shock, allergic asthma, anaphylaxis, rhinitis, allergic conjunctivitis, urticaria, atopic dermatitis, and pruritus.
AU2002221897A 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma Abandoned AU2002221897A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2000A000626 2000-11-26
IT2000RM000626A IT1317067B1 (en) 2000-11-29 2000-11-29 HISTAMINAS OF VEGETABLE ORIGIN IN THE TREATMENT OF ESPECTIC ALLERGIC SHOCK AND ALLERGIC ASTHMA.
PCT/EP2001/013770 WO2002043745A2 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma

Publications (1)

Publication Number Publication Date
AU2002221897A1 true AU2002221897A1 (en) 2002-06-11

Family

ID=11455023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221897A Abandoned AU2002221897A1 (en) 2000-11-29 2001-11-27 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma

Country Status (8)

Country Link
US (2) US20040115189A1 (en)
EP (1) EP1339422B1 (en)
AT (1) ATE349222T1 (en)
AU (1) AU2002221897A1 (en)
CA (1) CA2430291A1 (en)
DE (1) DE60125585D1 (en)
IT (1) IT1317067B1 (en)
WO (1) WO2002043745A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502098B8 (en) * 2004-07-07 2007-06-15 Albert Dr Missbichler DIAMOND OXIDASE-CONTAINING COMPOSITION
ES2540828T3 (en) * 2010-09-02 2015-07-13 Naturland Magyarország Termelö És Kereskedelmi Kft. Preparation applicable by peroral route containing histaminase of vegetable origin, resistant to pepsin and trypsin and a procedure to produce it
ES2387973B1 (en) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. TOPICAL COMPOSITIONS CONTAINING DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH A LEVEL OF ELEVATED HISTAMINE THAT PERFORM A PAIN INCREASE.
ES2388395B1 (en) 2011-03-18 2013-10-01 Dr Healthcare España, S. L. USE OF DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF FIBROMIALGIA OR CHRONIC FATIGUE.
ES2388515B1 (en) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. USE OF DIAMINOOXIDASE FOR THE PREVENTION OF THE SYMPTOMS OF THE BREAST.
CA2831535C (en) 2011-04-07 2014-10-21 Histapharm Inc. Oral enzyme compositions for intestinal delivery
ES2426539B1 (en) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. USE OF DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF THE DISORDER FOR DEFICIT OF CARE WITH HYPERACTIVITY (ADHD)
AU2020225319A1 (en) * 2019-02-19 2021-10-14 Medizinische Universität Wien New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6815177A (en) * 1968-10-24 1970-04-28
FR2101095A1 (en) * 1970-08-20 1972-03-31 Merieux Inst Diamine oxidase from human placenta - for treatment of hyperhistamina
FR2215944A1 (en) * 1973-02-01 1974-08-30 Bellon Labor Sa Roger Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies
US4725540A (en) * 1984-07-09 1988-02-16 Emil Underberg Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material
JPH0698026B2 (en) * 1987-12-28 1994-12-07 東洋紡績株式会社 Method for measuring polyamines
WO1990010061A1 (en) * 1989-03-02 1990-09-07 Griffith University Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
US5324510A (en) * 1989-09-01 1994-06-28 Boehringer Ingelheim Pharmaceuticals, Inc. Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
GB9715203D0 (en) * 1997-07-19 1997-09-24 Piper Edwina M Composition

Also Published As

Publication number Publication date
EP1339422B1 (en) 2006-12-27
ATE349222T1 (en) 2007-01-15
WO2002043745A3 (en) 2003-04-10
WO2002043745A2 (en) 2002-06-06
ITRM20000626A0 (en) 2000-11-29
EP1339422A2 (en) 2003-09-03
CA2430291A1 (en) 2002-06-06
DE60125585D1 (en) 2007-02-08
US20040115189A1 (en) 2004-06-17
IT1317067B1 (en) 2003-05-26
ITRM20000626A1 (en) 2002-05-29
US20080279840A1 (en) 2008-11-13
US8722038B2 (en) 2014-05-13

Similar Documents

Publication Publication Date Title
MXPA03001960A (en) A method for treating allergies.
WO2003105917A3 (en) Bulking agents
WO2007073505A3 (en) Trpa1 inhibitors for treating pain
EP1502933A3 (en) Hydrophobic inorganic fine particles, hydrophobic inorganic fine particles production process, and toner
MX2008002792A (en) Antimicrobial treatment of nonwoven materials for infection control.
WO2001056466A3 (en) Method for evaluating novel stroke treatments using a tissue risk map
AU2003227201A1 (en) Treating device for element to be treated and treating method
MXPA03001268A (en) Non-imidazole aryloxypiperidines.
WO2004043218A3 (en) Surgical tools and techniques for stimulation
NZ593182A (en) Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
WO2004101889A3 (en) Use of hemicellulase composition in mechanical pulp production
WO2008016708A3 (en) Methods for treatment of radiation enteritis
WO2007028088A3 (en) Methods for enhancing the dewaterability of sludge with alpha-amylase treatment
UA96164C2 (en) Method for processing sludge
AU2003246883A1 (en) Method for treating water containing iron, manganese and arsenic
AU2002221897A1 (en) Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
WO2004093995A3 (en) Use of antioxidants to treat bone loss disorders
WO2006133276A3 (en) Methods for dissolving cystine stones and reducing cystine in urine
WO2003015149A1 (en) Heat treatment method and heat treatment device
WO2007025064A3 (en) METHODS OF USING SELECTIVE llβ-HSD INHIBITORS TO TREAT GLUOCORTICOID ASSOCIATED STATES
EP1598122A4 (en) Method of treating organic waste, agent for treating organic waste and microorganisms to be used therein
HK1087328A1 (en) Therapeutic composition for autoimmune conditions
WO2006116374A3 (en) Surface treatments for promoting selective tissue attachment to medical implants
WO2003090598A3 (en) Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
WO2007024517A3 (en) Electrochemical recovery of arsenic